1. Home
  2. HFFG vs CMPX Comparison

HFFG vs CMPX Comparison

Compare HFFG & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HF Foods Group Inc.

HFFG

HF Foods Group Inc.

HOLD

Current Price

$2.60

Market Cap

136.3M

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$5.18

Market Cap

752.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HFFG
CMPX
Founded
1997
2014
Country
United States
United States
Employees
1074
N/A
Industry
Food Distributors
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
136.3M
752.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HFFG
CMPX
Price
$2.60
$5.18
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
$13.44
AVG Volume (30 Days)
79.3K
1.9M
Earning Date
11-10-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,225,541,000.00
N/A
Revenue This Year
$4.36
N/A
Revenue Next Year
$3.35
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.10
N/A
52 Week Low
$1.70
$1.33
52 Week High
$4.93
$5.86

Technical Indicators

Market Signals
Indicator
HFFG
CMPX
Relative Strength Index (RSI) 55.07 55.26
Support Level $2.54 $5.09
Resistance Level $2.79 $5.44
Average True Range (ATR) 0.12 0.34
MACD 0.02 -0.05
Stochastic Oscillator 55.67 41.59

Price Performance

Historical Comparison
HFFG
CMPX

About HFFG HF Foods Group Inc.

HF Foods Group Inc is an Asian food service distributor that markets and distributes fresh produce, seafood, frozen and dry food, and non-food products to Asian restaurants and other food service customers throughout the United States. The company's business consists of one operating segment; HF Group, which operates solely in the United States. The company's customer base consists of Chinese and Asian restaurants, and it provides sales and service support to customers who mainly converse in Mandarin or Chinese dialects.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

Share on Social Networks: